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The use of molecular tools in epidemiological investigations has provided new insights into the transmission of cryp-
tosporidiosis in humans and animals. This study aimed to characterize the transmission of cryptosporidiosis in human 
immunodeficiency virus (HIV)-infected patients. Stool specimens were collected from 500 HIV-infected patients as 
part of the routine patient care. Cryptosporidium species in stool specimens were detected and differentiated using 
a small subunit rRNA-based polymerase chain reaction-restriction fragment length polymorphism technique. C. hominis 
and C. parvum were found and subtyped by DNA sequence analysis of the 60 kDa glycoprotein (gp60) gene. Cryptosporidium 
species were detected in 36 HIV patients and none were found among non-HIV patients. A CD4+ count < 200 cells/μL 
was a significant risk factor for acquiring cryptosporidiosis (odds ratio = 21.214; 95% confidence interval = 9.917, 
45.381; p < 0.0001). Cryptosporidium infection was also associated with weight loss and diarrhea. Other risk factors 
included animal contact, and using stream/river or well water as drinking water. Genotyping of the Cryptosporidium 
species identified the presence of C. hominis (47.2%), C. parvum (44.4%), C. felis (5.6%) and C. canis (2.8%). The 
C. hominis specimens subtyped belonged to the Ia, Ib and Ie subtype families, whereas those of C. parvum belonged 
to the IIc and two new subtype families. Anthroponotic transmission appears to be important in cryptosporidiosis epi-
demiology in HIV-infected persons in Nigeria despite the high frequency of C. parvum infection and the identification 
of animal contact as a risk factor.
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Introduction
Cryptosporidiosis is a common cause of diarrhea in 
both immunocompetent and immunodeficient hu-
mans and animals.1 Five Cryptosporidium species, 
C. hominis, C. parvum, C. meleagridis, C. felis and 
C. canis, are responsible for most human cases of 
cryp to sporidiosis.2 However, a few other Cryptosporid-
ium species and genotypes are occasionally found 
in humans, including C. muris, C. suis, C. andersoni, 
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Cryptosporidium cervine, horse, rabbit and skunk 
genotypes, pig genotype II, and chipmunk geno-
type I.1 The prevalence of various species differs 
depending on the geographical location.
The use of molecular tools in epidemiological 
investigations has provided new insights into the 
transmission of cryptosporidiosis in humans and 
animals.1,3 In addition to the identification of infection 
sources and transmission routes, a number of stud-
ies have linked various Cryptosporidium species or 
subtypes to different clinical manifestations.1,3−6
Data are lacking on molecular epidemiology of 
cryptosporidiosis in Nigeria. This study aimed to 
genotype and subtype Cryptosporidium from human 
immunodeficiency virus (HIV) patients in Benin City, 
Nigeria and to identify likely infection sources.
Materials and Methods
Study population
The study was carried out from June 2008 to June 
2009 at the University of Benin Teaching Hospital, 
a tertiary referral health institution and a center 
for HIV/AIDS management under the President 
Emergency Plan for AIDS Relief. A total of 500 adult 
patients attending the University of Benin Teaching 
Hospital were enrolled in this study, including 400 
HIV patients and 100 non-HIV patients. A pre-
designed structural questionnaire was used to collect 
socio-demographic characteristics of the patients. 
Informed consent was obtained from all study 
patients. The study was approved by the Ethical 
Committee of the University of Benin Teaching 
Hospital, Benin City, Nigeria.
Sample collection
Stool samples were collected from each patient. 
The stool samples were preserved in 2.5% potas-
sium dichromate and stored at 4ºC. Aliquots of the 
Cryptosporidium-positive samples were shipped to 
the Centers for Disease Control (Atlanta, USA) for 
molecular analysis.
Extraction of Cryptosporidium 
genomic DNA
DNA was extracted from fecal specimens after they 
were washed off of potassium dichromate with dis-
tilled water by centrifugation. The FastDNA SPIN 
kit for soil (BIO 101, Carlsbad, CA, USA) was used 
for DNA extraction.7 All DNA preparations were 
analyzed by a polymerase chain reaction (PCR)-
restriction fragment length polymorphism technique 
that detects and differentiates Cryptosporidium 
species.4,8 Using this technique, an approximately 
830-bp fragment of the Cryptosporidium small 
subunit rRNA gene was amplified by nested PCR. 
Primers and amplification conditions used in this 
study have been described previously.3
Subtyping
C. hominis and C. parvum were categorized into 
subtype families (Ia, Ib, Id, Ie, and If for C. hom-
inis, and IIa, IIb, IIc, IId, IIe and IIf for C. parvum) 
by sequence analysis of the gp60 gene.4,8 The rec-
ommended subtype nomenclature was used in 
naming C. hominis and C. parvum subtypes.1
Statistical analysis
The frequency data were compared using the 
χ2 test. Odd ratios (OR) were calculated for each 
potential risk factor. The software INSTAT 
(GraphPad Software Inc., La Jolla, CA, USA) was 
used in all statistical analyses.
Results
Cryptosporidium species were detected in 36 of 
the 400 HIV patients and none were found in the 
100 non-HIV patients. The effects of demograph-
ics, CD4 counts and clinical manifestation on the 
prevalence of cryptosporidiosis are shown in Table 1. 
A CD4+ cell count of less than 200 cells/μL was sig-
nificantly associated with the occurrence of cryp-
tosporidiosis (p < 0.0001). Other risk factors for ac-
quiring cryptosporidiosis included female sex (OR = 
1.185), streams and rivers as the drinking source of 
water (OR = 4.241), and contact with animals, es-
pecially cattle (OR = 3.963). The prevalence of 
cryptosporidial infection was not significantly dif-
ferent (p > 0.05) in relation to age, level of education, 
or occupation of the study patients. Crypto-
sporidiosis was significantly associated with the 
occurrence of diarrhea (OR = 16.573) and weight loss 
(OR = 4.844) in HIV patients.
Restriction fragment length polymorphism 
analysis of the small subunit rRNA PCR products 
suggested the presence of four species of 
Cryptosporidium in HIV-infected patients, including 
C. hominis (17 patients), C. parvum (16 patients), 
C. felis (2 patients), and C. canis (1 patient) (Table 2). 
DNA sequencing of five PCR products of C. hominis 
and C. parvum, and all C. canis and C. felis PCR 
products confirmed species identification, with DNA 
sequences that were identical to those deposited in 
GenBank for the four Cryptosporidium species.
Nine C. hominis and eight C. parvum-positive 
specimens generated the expected PCR products. 
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Six subtypes in three well-known subtype families, 
Ia, Ib, and Ie, were identified in C. hominis by DNA 
sequencing. In contrast, two subtypes of the IIc 
subtype family and two subtypes representing two 
new subtype families were observed in C. parvum 
(Table 3). One of the new C. parvum subtype fami-
lies was very similar to the C. hominis subtype family 
Id, with the presence of only eight nucleotide 
substitutions and a 3-bp deletion downstream of 
the trinucleotide repeat region, and it was observed 
in three specimens. The other new C. parvum 
subtype family was very similar to the IIe subtype 
family, with only eight nucleotide substitutions 
downstream of the trinucleotide repeat region, 
Table 1  Effect of demographics and CD4 count on the prevalence of cryptosporidiosis among human immunodeficiency 
virus patients
Demographics
 No. No. with 
Prevalence (%) OR 95% CI p tested infection
Gender
 Male 170 11 6.47 0.844 0.405, 1.760
 Female 330 25 7.58 1.185 0.568, 2.474 0.787
CD4 count (cells/μL)
 < 200  54 22 40.74 21.214 9.917, 45.381
 ≥ 200 446 14 3.14 0.047 0.022, 0.101 < 0.0001*
Clinical manifestation
 Weight loss 321 32 9.97 4.844 1.684, 13.934 0.0025
 Without weight loss 179  4 2.23 0.206 0.072, 0.594 
 Diarrhea  23 11 47.83 16.573 6.657, 41.260 < 0.0001*
 Without diarrhea 477 25 5.24 0.060 0.024, 0.150
Age (yr)
 21−30 198 15 7.58
 31−40 180 13 7.22
 41−50  89  6 6.74
 51−60   27  1 3.70
 ≥ 61  6  1 16.67     0.850
Level of education
 No formal  15  0 0.00
 Primary   85  8 9.41
 Secondary   57 24 6.72
 Tertiary   43  4 9.30     0.534
Marital status
 Single  24  6 25.00 4.956 1.831, 14.409
 Married 476 30 6.30 0.202 0.075, 0.546 0.0023*
Source of water
 Treated (pipe borne)  31  2 6.45
 Borehole 418 26 6.22
 Well/rain  29  3 10.34
 Stream/river  22  5 22.73     0.029*
Contact with animals
 Animal contact  45  9 20.00 3.963 1.732, 9.068
 No animal contact 455 27 5.93 0.252 0.110, 0.577 0.0015*
Occupation
 Civil servant  48  5 10.42
 Business man/woman  21  3 14.29
 Security officer  4  0 0.00
 Artisan  39  3 7.69
 Trader 366 23 6.28
 Farmer  3  0 0.00
 House wife  10  1 10.00
 Student  9  1 11.11   0.818
*p < 0.05. OR: odds ratio; CI: confidence interval.
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and it was found in only one specimen. Episodes of 
diarrhea and weight loss were highly significant in 
the C. hominis and subtype family Ia.
Discussion
The transmission dynamics and pathogenicity of 
different species and subtypes of Cryptosporidium 
species are well studied. However, data on the re-
lationship between demographics and genotype- or 
subtype-specific cryptosporidiosis are limited, and 
there are no data from Nigeria. This study examined 
the molecular typing of Cryptosporidium parasites 
and risk factors associated with the acquisition of 
cryptosporidiosis.
We observed a prevalence of 9% of crypto-
sporidial infection among HIV-infected patients. 
This finding is lower than the prevalence rates of 
10−52.7% reported in previous studies in Nigeria,9,10 
although some studies have reported no crypto-
sporidial infection in HIV-infected patients.11 The 
type of method used for detection and geographi-
cal locations has been reported to affect the preva-
lence of cryptosporidiosis.12 Notably, the prevalence 
of this coccidian tends to vary from one locality to 
another and from one country to another based on 
the extent of contamination of food, water, and 
contact with animals, which are all important fac-
tors of dissemination of the parasite.10 Furthermore, 
sample size may also play a role, since our previous 
study with a sample size of 200 revealed a preva-
lence of 18%.9
CD4 counts < 200 cells/μL have been reported 
as a risk factor for cryptosporidial infection in 
Nigeria,9 which is in agreement with the findings 
in this study. Other risk factors that have been as-
sociated with cryptosporidiosis include sexual be-
havior patterns, contact with animals,4 and a lack 
of access to potable drinking water.13 In this study, 
being single, using streams or rivers as a source of 
water, and contact with animals, especially cattle, 
were significantly associated with the occurrence 
of cryptosporidial infection. Drinking contaminated 
water is a mode of transmission of cryptosporidio-
sis.14 In our study, patients who used streams and 
rivers as a source of water had a high prevalence 
of cryptosporidial infection.
The species of Cryptosporidium recovered in 
this study have been previously reported in HIV-
infected patients.4,15 In most studies, C. hominis 
and C. parvum are the most common species that 
cause human infections, including infection in HIV 
patients,1,4 which is consistent with the findings 
from this study. We also found C. felis and C. canis.
Three C. hominis subtype families were ob-
served in this study, including Ia, Ib, and Ie, and Ie 
was predominant. The subtype IeA11G3T3 was the 
only subtype of Ie observed. This subtype has been 
reported in human infections from developing 
countries.1 The Ie subtypes were from patients 
who used streams/rivers as a source of water, and 
this may indicate waterborne transmission. Analysis 
of streams and rivers for Cryptosporidium species 
is needed to confirm this theory. Other subtypes, 
with the exception of IaA14R3, were from patients 
who used boreholes as a source of water. All of the 
C. hominis infections were observed in traders and 
none were found in patients who had contact with 
animals. These findings confirm that C. hominis is 
an anthroponotic species.16 The Ib subtype found 
in this study, IaA13G3, differs from IbA10G2 and 
IbA9G3 commonly found in humans in most indus-
trialized and developing countries.1 This subtype, 
however, was recently found in children17 in Nigeria, 
thus representing a unique C. hominis subtype in 
Nigeria. Molloy et al17 observed a high Cryptospori-
dium diversity in a population of pediatrics in 
Nigeria where the subtypes Ia, Ib, Id, Ie, and Ih of 
C. hominis, and IIa, IIc, IIi and IIm of C. parvum were 
reported. Findings in our study were similar to those 
of Molloy et al,17 except for Ih of C. hominis, and IIi 
and IIm of C. parvum.
For C. parvum, we found the anthroponotic IIc 
subtype family and two new subtype families. As 
expected, the zoonotic IIa and IId subtype families 
found in humans in industrialized nations and 
Table 2 Distribution of species
Cryptosporidium No. %
C. hominis 17 47.2
C. parvum 16 44.4
C. canis  1  2.8
C. felis  2  5.6
Total 36 
Table 3 Distribution of subtype family
Cryptosporidium species No.
C. hominis 
 IaA14R3 1
 IaA16R3 1
 IaA24R3 1
 IaA25R3 1
 IbA13G3 2
 IeA11T3G3 3
C. parvum
 IIcA5G3a 2
 IIcA5G3h 2
 New subtype family 1 3
 New subtype family 2 1
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Mideast countries were not observed in this study, 
suggesting that the transmission of C. parvum in 
humans in Nigeria is anthroponotic in nature. 
C. parvum transmission in developing countries ap-
pears largely anthroponotic with the subtype family 
IIc predominating in human infections.1 Therefore, 
the identification of contact with animals as a risk 
factor in this study might simply be a marker for 
other risk factors, such as poor sanitation condi-
tions. Since all C. parvum subtype families were 
recovered from patients who used boreholes as 
a source of water, waterborne transmission of 
human origin C. parvum could have been responsi-
ble in addition to person-to-person transmission. 
Boreholes have been reported to be a source of 
cryptosporidial infection.18 Unlike the borehole 
supplies studied by Willocks et al,18 boreholes in our 
locality do not undergo any treatment. The water is 
collected from the borehole and used directly for 
drinking and other domestic purposes. Further stud-
ies are required to identify Cryptosporidium sub-
types in different water sources in Nigeria to 
provide data on transmission routes of cryptosporid-
iosis and the importance of waterborne infections.
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